Russo V - Search Results

1

Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity.

Russo V, Cipponi A, Raccosta L, Rainelli C, Fontana R, Maggioni D, Lunghi F, Mukenge S, Ciceri F, Bregni M, Bordignon C, Traversari C. Russo V, et al. J Clin Invest. 2007 Oct;117(10):3087-96. doi: 10.1172/JCI30605. J Clin Invest. 2007. PMID: 17885685 Free PMC article.

2

Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy.

Russo V, Traversari C, Verrecchia A, Mottolese M, Natali PG, Bordignon C. Russo V, et al. Int J Cancer. 1995 Jun 22;64(3):216-21. doi: 10.1002/ijc.2910640313. Int J Cancer. 1995. PMID: 7622312

3

Functional heterogeneity of HLA-A*02 subtypes revealed by presentation of a MAGE-3-encoded peptide to cytotoxic T cell clones.

Fleischhauer K, Tanzarella S, Russo V, Sensi ML, van der Bruggen P, Bordignon C, Traversari C. Fleischhauer K, et al. Among authors: russo v. J Immunol. 1997 Sep 1;159(5):2513-21. J Immunol. 1997. PMID: 9278345

4

High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: implications for protocol design of therapeutic antigen-specific vaccination strategies.

Dalerba P, Ricci A, Russo V, Rigatti D, Nicotra MR, Mottolese M, Bordignon C, Natali PG, Traversari C. Dalerba P, et al. Among authors: russo v. Int J Cancer. 1998 Jul 17;77(2):200-4. doi: 10.1002/(sici)1097-0215(19980717)77:2<200::aid-ijc5>3.0.co;2-u. Int J Cancer. 1998. PMID: 9650552

5

Major histocompatibility complex class I restricted cytotoxic T cells specific for natural melanoma peptides recognize unidentified shared melanoma antigen(s).

Imro MA, Manici S, Russo V, Consogno G, Bellone M, Rugarli C, Traversari C, Protti MP. Imro MA, et al. Among authors: russo v. Cancer Res. 1999 May 15;59(10):2287-91. Cancer Res. 1999. PMID: 10344730

6

Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family.

Tanzarella S, Russo V, Lionello I, Dalerba P, Rigatti D, Bordignon C, Traversari C. Tanzarella S, et al. Among authors: russo v. Cancer Res. 1999 Jun 1;59(11):2668-74. Cancer Res. 1999. PMID: 10363990

7

Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.

Chaux P, Luiten R, Demotte N, Vantomme V, Stroobant V, Traversari C, Russo V, Schultz E, Cornelis GR, Boon T, van der Bruggen P. Chaux P, et al. Among authors: russo v. J Immunol. 1999 Sep 1;163(5):2928-36. J Immunol. 1999. PMID: 10453041

8

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response.

Russo V, Tanzarella S, Dalerba P, Rigatti D, Rovere P, Villa A, Bordignon C, Traversari C. Russo V, et al. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2185-90. doi: 10.1073/pnas.040540197. Proc Natl Acad Sci U S A. 2000. PMID: 10681453 Free PMC article.

9

Acquisition of intact allogeneic human leukocyte antigen molecules by human dendritic cells.

Russo V, Zhou D, Sartirana C, Rovere P, Villa A, Rossini S, Traversari C, Bordignon C. Russo V, et al. Blood. 2000 Jun 1;95(11):3473-7. Blood. 2000. PMID: 10828031 Free article.

10

Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies.

Tanzarella S, Lionello I, Valentinis B, Russo V, Lollini PL, Traversari C. Tanzarella S, et al. Among authors: russo v. Cancer Immunol Immunother. 2004 Jun;53(6):519-24. doi: 10.1007/s00262-003-0484-6. Epub 2004 Jan 16. Cancer Immunol Immunother. 2004. PMID: 14727086 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,410 results

Search Page

Filters